Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline for cSSSI in Hospitalized Patients
NCT00488761Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of tigecycline in Skin and Skin Structure Infection (SSSI), sponsored by Pfizer. Started Jul 2006; status: completed.
02
Drugs
tigecycline
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00488761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488761.